|
|
|
Insider
Information: |
Sigal Elliot |
Relationship: |
Director |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
148,221 |
|
Indirect Shares
|
78,638 |
|
|
Direct
Value |
$6,188,227 |
|
|
Indirect Value
|
$5,549,704 |
|
|
Total
Shares |
226,859 |
|
|
Total
Value |
$11,737,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
EVP, CSO & President R... |
2013-06-03 |
148,221 |
2013-06-03 |
47,079 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2017-06-15 |
0 |
Premium* |
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2015-02-04 |
31,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,796) |
207,107 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
441 |
212,903 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,062 |
212,462 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-04 |
4 |
D |
$26.43 |
$91,316 |
D/D |
(3,455) |
211,104 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,452 |
214,559 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-06 |
4 |
D |
$26.43 |
$84,232 |
D/D |
(3,187) |
214,792 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,875 |
217,979 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-07 |
4 |
D |
$26.31 |
$93,506 |
D/D |
(3,554) |
211,238 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-16 |
4 |
D |
$28.90 |
$6,609,201 |
D/D |
(228,681) |
171,352 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-16 |
4 |
S |
$28.90 |
$2,046,265 |
D/D |
(70,805) |
372,572 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-16 |
4 |
OE |
$28.90 |
$7,502,803 |
D/D |
259,600 |
470,838 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-18 |
4 |
D |
$28.70 |
$4,313,747 |
D/D |
(150,299) |
205,902 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-18 |
4 |
S |
$28.70 |
$20,952 |
D/D |
(730) |
356,201 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-18 |
4 |
OE |
$28.70 |
$5,326,321 |
D/D |
185,579 |
356,931 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,173 |
220,789 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,714 |
217,616 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-01 |
4 |
D |
$32.64 |
$176,648 |
D/D |
(5,412) |
215,377 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-02 |
4 |
D |
$32.59 |
$240,612 |
D/D |
(7,383) |
223,922 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,866 |
231,305 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,062 |
227,439 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,365 |
270,287 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-03 |
4 |
D |
$32.59 |
$700,392 |
D/D |
(21,491) |
248,796 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-04 |
4 |
D |
$32.59 |
$112,598 |
D/D |
(3,455) |
252,794 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,453 |
256,249 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-06 |
4 |
D |
$32.33 |
$1,286,217 |
D/D |
(39,784) |
298,840 |
0 |
- |
|
133 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|